The FDA has approved the first new treatment in 15 years for an aggressive form of lung cancer.

The device, the NovoTTF-100L System made by Novocure, uses electric fields to stop solid tumors from mesothelioma from dividing.

Mesothelioma is aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products.
The new device was approved under the Humanitarian Device Exemption, which was created to encourage innovation in rare diseases.

Mary Hesdorffer, a nurse practitioner and executive director of the Mesothelioma Applied Research Foundation, says the approval is a new option. “Typically, mesothelioma patients who cannot have surgery receive palliative care to mitigate their symptoms,” she says in a statement. The new treatment gives patients “a treatment option that may improve survival.”

The FDA approved Optune, another Novocure device, for the treatment of a kind of brain cancer, glioblastoma, in 2011.

Source: WebMD,

  1. May 27, 2019

    Yes, this is true. In fact few days back I was reading about the same thing in an article online which clearly stated that FDA has approved a tumor treating fields or TTF device in combination with pemetrexed plus platinum-based chemotherapy for the first-line treatment of unresectable, locally advanced or metastatic, malignant pleural mesothelioma.

Write a comment:


Your email address will not be published.

The National Drug and Poison Information Center 1-800-222-1222

Copyright @ 2012-2019 All Rights Reserved. My Pharmacy Visit does not provide medical advice, diagnosis, or treatment.

Skip to toolbar